Skip to main content
. 2020 Oct 19;13:2653–2662. doi: 10.2147/JPR.S270698

Table 3.

Characteristics and Changes in Secondary Outcomes from Baseline and Multiple Comparisons

Outcomes (N=64) (N=68) (N=76) Value of Pairwise Comparison
Group A Group B Group C Group A vs Group B Group A vs Group C Group B vs Group C
Difference (95% Cl)a Pb Difference (95% Cl)a Pb Difference (95% Cl)a Pb
Pain intensity rating of VAS, meridian (Q1-Q3)
0 month 6.00 (5.00, 7.00) 6.00 (5.00, 7.00) 5.00 (4.00, 7.00)
1 month 4.00 (3.00, 5.00) 4.00 (3.00, 5.00) 5.00 (4.00, 6.50) 0.06 (−0.32, 0.44) 1.000 −1.63 (−2.01, −1.24) <0.001 −1.69 (−2.04, −1.33) <0.001
2 month 2.00 (2.00, 3.00) 3.00 (2.00, 3.00) 5.50 (4.00, 7.00) −0.07 (−0.60, 0.46) 1.000 −3.01 (−3.54, −2.48) <0.001 −2.94 (−3.43, −2.45) <0.001
3 month 0.50 (0.00, 1.00) 2.00 (0.00, 3.00) 6.00 (4.00, 7.00) −1.01 (−1.68, −0.34) 0.001 −4.75 (−5.43, −4.08) <0.001 −3.75 (−4.37, −3.12) <0.001
4 month 0.50 (0.00, 1.00) 2.00 (0.00, 3.00) −0.85 (−1.49, −0.21) 0.010
5 month 0.00 (0.00, 1.00) 1.00 (0.00, 3.00) −0.85 (−1.51, −0.20) 0.011
6 month 0.00 (0.00, 1.00) 1.00 (0.00, 3.00) −0.96 (−1.64, −0.27) 0.007
Anxiety measured by SAS, meridian (Q1-Q3)
0 month 50.00 (40.00, 52.50) 50.00 (39.38, 53.75) 41.25 (33.75, 52.50)
3 month 37.50 (32.50, 40.00) 38.75 (35.00, 41.25) 43.75 (36.88, 52.50) −0.05 (−2.27, 2.16) 1.000 −9.88 (−12.08, −7.67) <0.001 −9.82 (−11.87, −7.77) <0.001
Depression measured by SDS, meridian (Q1-Q3)
0 month 50.00 (41.38, 55.63) 50.00 (42.50, 54.38) 50.00 (41.38, 55.63)
3 month 38.75 (33.75, 41.25) 39.38 (35.00, 43.75) 38.75 (33.75, 41.25) −0.98 (−3.26, 1.30) 0.908 −8.86 (−11.12, −6.59) <0.001 −7.88 (−9.99, −5.77) <0.001

Notes: aLeast squared mean adjusted for VAS score, depression score, anxiety score at baseline between and within groups (Bonferroni adjusted). bMultiple comparisons adjusted using the Bonferroni correction.